TGF-β induces M2-like macrophage polarization via SNAILmediated suppression of a pro-inflammatory phenotype

Oncotarget

Volumn 7, Issue 32, 2016, Pages 52294-52306

  Zhang, Fan ^a,b   Wang, Hongsheng ^b   Wang, Xianfeng ^c   Jiang, Guanmin ^d   Liu, Hao ^e   Zhang, Ge ^b   Wang, Hao ^b   Fang, Rui ^b   Bu, Xianzhang ^b   Cai, Shaohui ^f   Du, Jun ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Shijiazhuang City Center for Disease Control and Prevention   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

^f JINAN UNIVERSITY   (China)

Author keywords

Immunotherapy; Macrophage polarization; SNAIL; TGF ; Tumor associated macrophage

Indexed keywords

CYTOKINE; INTERLEUKIN 10; PROTEIN KINASE C; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PHENOTYPE; POLARIZATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED BALB C; PHENOTYPE; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84982279514     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10561     Document Type: Article

References (50)

1. Balkwill FR and Mantovani A. Cancer-related inflammation: Common themes and therapeutic opportunities. Seminars in Cancer Biology. 2012; 22:33-40.
2. Gordon S and Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010; 32:593-604.
3. Biswas SK, Allavena P and Mantovani A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Seminars in Immunopathology. 2013; 35:585-600.
4. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in immunology. 2002; 23:549-555.
5. Gordon S. Alternative activation of macrophages. Nature Reviews Immunology. 2003; 3:23-35.
6. Biswas SK and Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature immunology. 2010; 11:889-896.
7. Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC and Balkwill FR. "Re-educating" tumor-associated macrophages by targeting NF-κB. The Journal of experimental medicine. 2008; 205:1261-1268.
8. Mantovani A. From phagocyte diversity and activation to probiotics: back to Metchnikoff. European journal of immunology. 2008; 38:3269-3273.
9. Martinez FO, Helming L and Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annual review of immunology. 2009; 27:451-483.
10. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends in immunology. 2004; 25:677-686.
11. Sica A. Role of tumour-associated macrophages in cancerrelated inflammation. Exp Oncol. 2010; 32:153-158.
12. Satoh T, Kidoya H, Naito H, Yamamoto M, Takemura N, Nakagawa K, Yoshioka Y, Morii E, Takakura N and Takeuchi O. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature. 2013; 495:524-528.
13. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T and Saitoh T. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature immunology. 2010; 11:936-944.
14. Sinha P, Clements VK and Ostrand-Rosenberg S. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer research. 2005; 65:11743-11751.
15. Zhang B, Yao G, Zhang Y, Gao J, Yang B, Rao Z and Gao J. M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics. 2011; 66:1879-1886.
16. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, Ansell SM, Micallef IN, Johnston PB and Nowakowski GS. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica. 2012; 97:262-269.
17. Fujiwara T, Fukushi J-I, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K and Ono M. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. The American journal of pathology. 2011; 179:1157-1170.
18. Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M and Takeya M. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer science. 2011; 102:1424-1431.
19. Ma YY, He XJ, Wang HJ, Xia YJ, Wang SL, Ye ZY and Tao HQ. Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer. Cancer science. 2011; 102:336-342.
20. Qian B-Z and Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141:39-51.
21. Komohara Y, Jinushi M and Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer science. 2014; 105:1-8.
22. Jinushi M, Chiba S, Yoshiyama H, Masutomi K, Kinoshita I, Dosaka-Akita H, Yagita H, Takaoka A and Tahara H. Tumorassociated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proceedings of the National Academy of Sciences. 2011; 108:12425-12430.
23. Bowdish D, Loffredo M, Mukhopadhyay S, Mantovani A and Gordon S. Macrophage receptors implicated in the "adaptive" form of innate immunity. Microbes and Infection. 2007; 9:1680-1687.
24. Massagué J. TGFβ in cancer. Cell. 2008; 134:215-230.
25. Wrzesinski SH, Wan YY and Flavell RA. Transforming growth factor-β and the immune response: implications for anticancer therapy. Clinical Cancer Research. 2007; 13:5262-5270.
26. Li MO, Wan YY, Sanjabi S, Robertson A-KL and Flavell RA. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol. 2006; 24:99-146.
27. Flavell RA, Sanjabi S, Wrzesinski SH and Licona-Limón P. The polarization of immune cells in the tumour environment by TGFβ. Nature Reviews Immunology. 2010; 10:554-567.
28. Allavena P, Sica A, Garlanda C and Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunological reviews. 2008; 222:155-161.
29. Byrne SN, Knox MC and Halliday GM. TGFβ is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction. Immunology and cell biology. 2007; 86:92-97.
30. Wang H, Wang H-S, Zhou B-H, Li C-L, Zhang F, Wang X-F, Zhang G, Bu X-Z, Cai S-H and Du J. Epithelial-Mesenchymal Transition (EMT) Induced by TNF-a Requires AKT/GSK-3β-Mediated Stabilization of SNAIL in Colorectal Cancer. PloS one. 2013; 8:e56664.
31. Wu Y and Zhou BP. SNAIL: more than EMT. Cell adhesion & migration. 2010; 4:199-203.
32. Du F, Nakamura Y, Tan T-L, Lee P, Lee R, Yu B and Jamora C. Expression of snail in epidermal keratinocytes promotes cutaneous inflammation and hyperplasia conducive to tumor formation. Cancer Research. 2010; 70:10080-10089.
33. Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y. Cancer metastasis is accelerated through immunosuppression during SNAIL-induced EMT of cancer cells. Cancer cell. 2009; 15:195-206.
34. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM and Zhou BP. Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion. Cancer cell. 2009; 15:416-428.
35. Zavadil J and Böttinger EP. TGF-β and epithelial-tomesenchymal transitions. Oncogene. 2005; 24:5764-5774.
36. Mantovani A, Allavena P, Sica A and Balkwill F. Cancerrelated inflammation. Nature. 2008; 454:436-444.
37. Murray PJ and Wynn TA. Obstacles and opportunities for understanding macrophage polarization. Journal of leukocyte biology. 2011; 89:557-563.
38. Stein M, Keshav S, Harris N and Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. The Journal of experimental medicine. 1992; 176:287-292.
39. Martinez FO, Gordon S, Locati M and Mantovani A. Transcriptional profiling of the human monocyteto-macrophage differentiation and polarization: new molecules and patterns of gene expression. The Journal of Immunology. 2006; 177:7303-7311.
40. Rodríguez-Prados J-C, Través PG, Cuenca J, Rico D, Aragonés J, Martín-Sanz P, Cascante M and Boscá L. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. The Journal of Immunology. 2010; 185:605-614.
41. Elliott RL and Blobe GC. Role of transforming growth factor Beta in human cancer. Journal of Clinical Oncology. 2005; 23:2078-2093.
42. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani A. (2008). Macrophage polarization in tumour progression. Seminars in cancer biology: Elsevier), pp. 349-355.
43. Mantovani A and Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Current opinion in immunology. 2010; 22:231-237.
44. Torroella-Kouri M, Silvera R, Rodriguez D, Caso R, Shatry A, Opiela S, Ilkovitch D, Schwendener RA, Iragavarapu-Charyulu V and Cardentey Y. Identification of a Subpopulation of Macrophages in Mammary Tumor-Bearing Mice That Are Neither M1 nor M2 and Are Less Differentiated. Cancer research. 2009; 69:4800-4809.
45. Hotz B, Visekruna A, Buhr H-J and Hotz HG. Beyond epithelial to mesenchymal transition: A novel role for the transcription factor snail in inflammation and wound healing. Journal of Gastrointestinal Surgery. 2010; 14:388-397.
46. Peinado H, Olmeda D and Cano A. SNAIL, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Reviews Cancer. 2007; 7:415-428.
47. Xu J, Lamouille S and Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell research. 2009; 19:156-172.
48. De Craene B, Van Roy F and Berx G. Unraveling signalling cascades for the SNAIL family of transcription factors. Cellular signalling. 2005; 17:535-547.
49. Moustakas A and Heldin C-H. Non-Smad TGF-β signals. Journal of cell science. 2005; 118:3573-3584.
50. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M and Hung M-C. Dual regulation of SNAIL by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nature cell biology. 2004; 6:931-940.